Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,27 USD | -5,81% | -22,79% | +28,25% |
09/04 | TAYSHA GENE THERAPIES, INC. : Piper Sandler ontvangt een koopadvies | ZM |
21/03 | TAYSHA GENE THERAPIES, INC. : Chardan Research handhaaft koopadvies | ZM |
Omzet 2024 * | 9,22 mln. 8,65 mln. | Omzet 2025 * | 5,09 mln. 4,78 mln. | Marktkapitalisatie | 425 mln. 399 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -77 mln. -72,28 mln. | Nettowinst (verlies) 2025 * | -92 mln. -86,36 mln. | EV/omzet 2024 * | 35 x |
Nettoliquiditeiten 2024 * | 102 mln. 96,06 mln. | Nettoliquiditeiten 2025 * | 144 mln. 135 mln. | EV/omzet 2025 * | 55,2 x |
K/w-verhouding 2024 * |
-5,59
x | K/w-verhouding 2025 * |
-4,77
x | Werknemers | 52 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,23% |
Recentste transcriptie over Taysha Gene Therapies, Inc.
1 dag | -5,81% | ||
1 week | -22,79% | ||
Lopende maand | -20,91% | ||
1 maand | +0,89% | ||
3 maanden | +57,64% | ||
6 maanden | +9,66% | ||
Lopend jaar | +28,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 01-08-20 |
President | 58 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 31-08-20 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Sean Stalfort
BRD | Director/Board Member | 54 | 21-06-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 2,27 | -5,81% | 1 790 252 |
18-04-24 | 2,41 | -1,63% | 1 969 323 |
17-04-24 | 2,45 | -4,85% | 1 398 013 |
16-04-24 | 2,575 | -3,20% | 1 475 522 |
15-04-24 | 2,66 | -9,52% | 2 029 832 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+28,25% | 451 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |